Related Experiment Video
Updated: Jan 30, 2026

Assaying the Ability of Diffusible Signaling Molecules to Reorient Embryonic Spinal Commissural Axons
Published on: March 8, 2010
Signaling Molecules in Posttransplantation Cancer
Murugabaskar Balan1, Samik Chakraborty1, Soumitro Pal1
1Division of Nephrology, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA.
Abstract:
Immunosuppression is essential to prevent graft rejection. However, immunosuppression impairs the ability of the host immune system to control viral infection and decreases tumor immunosurveillance. Therefore, immunosuppression after organ transplantation is a major risk factor for posttransplantation cancer. Notably, recent reports suggest that immunosuppressive agents can activate tumorigenic pathways independent of the involvement of the host immune system. In this review, we focus on cell-intrinsic tumorigenic pathways directly activated by immunosuppressive agents and discuss the much-described infection- and immune-mediated mechanisms of cancer development in organ transplant recipients.
Related Concept Videos
Types of Signaling Molecules
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Bacterial Signaling
Paracrine Signaling
What is Cell Signaling?
Yeast Signaling

